Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Amy J. Pfizenmayer is active.

Publication


Featured researches published by Amy J. Pfizenmayer.


Bioorganic & Medicinal Chemistry Letters | 1998

Synthesis and biological activity of [Tic5] didemnin B

Amy J. Pfizenmayer; Matthew D. Vera; Xiaobin Ding; Dong Xiao; Wei-Chuan Chen; Madeleine M. Joullié; Deepika Tandon; Peter L. Toogood

A didemnin B analog containing a Tic (1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid) as a conformationally restrained replacement for tyrosine has been synthesized and shown to have comparable potency as a protein biosynthesis inhibitor. Synthetic highlights include an oxidation of an alcohol to an acid in the presence of the sensitive Tic heterocycle and a modified Schmidt-type one-pot macrocyclization.


Tetrahedron | 1999

Synthesis and biological activities of [N-MeLeu5]- and [N-MePhe5]-didemnin B

Amy J. Pfizenmayer; Joshi M. Ramanjulu; Matthew D. Vera; Xiaobin Ding; Dong Xiao; Chen Wei-Chuan; Madeleine M. Joullié

Abstract Based on information from X-ray, NMR, and SAR data, the N , O -diMeTyr 5 unit of didemnin B was believed to be important for biological activity. To determine the importance of aromaticity and the role of the methoxy group in this unit, two analogs were synthesized in which the N , O -diMeTyr 5 moiety was replaced with N -MeLeu and N -MePhe. Preliminary testing showed that the analogs retained antitumor activity and the ability to inhibit protein biosynthesis in vitro .


Bioorganic & Medicinal Chemistry Letters | 2001

[Lys3]Didemnins as potential affinity ligands.

Matthew D. Vera; Amy J. Pfizenmayer; Xiaobin Ding; Dong Xiao; Madeleine M. Joullié

The synthesis and biological activity of N(epsilon)-Z-[Lys3]didemnin B are reported. This novel analogue retains antiproliferative, cytotoxic, and protein biosynthesis inhibition activities, but at reduced levels. This result suggests the use of [Lys3]didemnin derivatives as potential affinity probes for studying the molecular target(s) of the didemnin class of natural products.


Bioorganic & Medicinal Chemistry Letters | 1996

Synthesis and biological activities of [N-MeLeu5] didemnin B

Amy J. Pfizenmayer; Joshi M. Ramanjulu; Matthew D. Vera; Xiaobin Ding; Dong Xiao; Wei-Chuan Chen; Madeleine M. Joullié

Abstract Based on information from X-ray, NMR, and SAR data, the N,O-diMeTyr5 unit of didemnim B was believed to interact with receptors. To ascertain the importance of this unit, an analog was synthesized in which the N,O-diMeTyr5 moiety was replaced with N-McLeu. Preliminary biological testing showed that the analog retained antitumor activity and the ability to inhibit protein biosynthesis.


Tetrahedron-asymmetry | 1994

Synthetic studies of a constrained ring didemnin analog

Scott C. Mayor; Amy J. Pfizenmayer; Richard Cordova; Wen-Ren Li; Madeleine M. Joullié

Abstract An asymmetric Diels-Alder reaction in the presence of 3.0 M lithium perchlorate-diethyl ether was used to generate the initial stereochemistry for a cyclohexane amino acid ( 3 ), a key intermediate in the preparation of a fused ring didemnin analog. This constrained ring macrocycle should provide insight into the binding site conformation of the bioactive species.


Bioorganic & Medicinal Chemistry Letters | 2001

Synthesis and biological evaluation of didemnin photoaffinity analogues

Matthew D. Vera; Amy J. Pfizenmayer; Xiaobin Ding; Deepika Ahuja; Peter L. Toogood; Madeleine M. Joullié

The synthesis of four benzophenone-containing analogues of the antiproliferative natural product didemnin B is presented. In vitro protein biosynthesis inhibition potency and antitumor activity were evaluated. The results indicate that all four analogues are biologically active and could serve as photoaffinity reagents for the study of receptor-binding interactions of didemnins. These analogues could also be useful in studying antitumor effects of didemnins.


Tetrahedron-asymmetry | 1997

Stereoselective synthesis of a conformationally restricted β-hydroxy-λ-amino acid

Dong Xiao; Patrick J. Carroll; Scott C. Mayer; Amy J. Pfizenmayer; Madeleine M. Joullié

Abstract β-Hydroxy-λ-amino acids are a class of non-proteinogenic amino acids present in many important biologically active natural products. In conjunction with our research on didemnins, we designed and synthesized a sterically constrained β-hydroxy-λ-amino acid in which the requisite carboxyl, hydroxyl and amino groups are positioned on a conformationally stable 6-membered ring.


Journal of Organic Chemistry | 1994

Synthesis of new didemnin B analogs for investigations of structure/biological activity relationships

Scott C. Mayer; Joshi M. Ramanjulu; Matthew D. Vera; Amy J. Pfizenmayer; Madeleine M. Joullié


Journal of Medicinal Chemistry | 2000

Inhibition of protein synthesis by didemnins : Cell potency and SAR

Deepika Ahuja; Adam Geiger; Joshi M. Ramanjulu; Matthew D. Vera; SirDeshpande Bv; Amy J. Pfizenmayer; Mohamed E. Abazeed; Daniel J. Krosky; David R. Beidler; Madeleine M. Joullié; Peter L. Toogood


Tetrahedron | 1999

Synthesis and biological activities of [ N-MeLeu 5]- and [ N-MePhe 5]-didemnin B

Amy J. Pfizenmayer; Joshi M. Ramanjulu; Matthew D. Vera; Xiaobin Ding; Dong Xiao; Wei-Chuan Chen; Madeleine M. Joullié

Collaboration


Dive into the Amy J. Pfizenmayer's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Matthew D. Vera

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Dong Xiao

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Xiaobin Ding

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Wei-Chuan Chen

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Scott C. Mayer

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Adam Geiger

University of Michigan

View shared research outputs
Researchain Logo
Decentralizing Knowledge